Loading
SW
Shandong Wit Dyne Health Co.,Ltd. Stock: price and insider trades · China
华特达因
No insider purchase over the last 90 days. The latest, by 范智胜, was filed 24 Apr 2026.
Shandong Wit Dyne Health Co.,Ltd.: what insiders have been doing
Shandong Wit Dyne Health Co.,Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). In the past year (26 October 2025 to 26 October 2026), 4 filings came from 4 insiders.
The flow runs one way only: 4 insiders bought (4 purchases totalling €251k) and nobody sold on the market. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 3 board members and 1 senior executive among the declarants. The largest single trade was a purchase of €179k by 杨杰, published on 24 April 2026.
For context, the typical company on the same exchange (median of 533 companies) published 2 filings over the same period, against 4 filings here. Since 2026, the database holds 4 purchases and no sales by insiders of the company.
In all, 4 purchases were made within 30 days of a purchase by another insider of the company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The most recent open-market purchase was published on 24 April 2026, 185 days ago. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done.
Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Insider Decl.
4
Thresholds
n/a
Buy Volume
€250,502
4 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySale何淑旺1 buy
杨杰1 buy
王龙江1 buy
范智胜1 buy
Since the insiders bought
- -12.0%Entry CN¥28.10 · Close at T+90 CN¥24.73
- -12.0%Entry CN¥28.10 · Close at T+90 CN¥24.73
- -12.0%Entry CN¥28.10 · Close at T+90 CN¥24.73
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 119 of 26,320 companies
90.3
score / 100
Value89
Quality92
FCF yld21%
Earn yld9.1%
EV/EBITDA4.7x
ROE20%
Gross mgn85%
Net mgn24%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥25.84
Analyst consensus
Income statement
RevenueCN¥2.2B
Gross profitCN¥1.9B85% margin
EBITDACN¥1.3B57% margin
Net incomeCN¥535.1M22.9% margin
Valuation
PER (trailing)13.1x
P/Book2.0x
Beta0.06
Balance sheet & cash
Market capCN¥6.1B
Total debtCN¥7.9M
Free Cash FlowCN¥1.2B
Profitability & ownership
ROE20.2%
ROA12.5%
% insiders35.3%
% institutions9.3%
Last declaration on 24 April 2026
Declarations4 total
5,000 shares100.0% of flowA股XSHESZSE:273000000515452260
Canonical exit: 23 Jul 2026 (T+90)
10,100 shares100.0% of flowA股XSHESZSE:273000000515452320
Canonical exit: 23 Jul 2026 (T+90)
5,000 shares100.0% of flowA股XSHESZSE:273000000515452350
Canonical exit: 23 Jul 2026 (T+90)
50,000 shares100.0% of flowA股XSHESZSE:273000000515452380
Canonical exit: 23 Jul 2026 (T+90)
4 of 4 declarations
About Shandong Wit Dyne Health Co.,Ltd.
华特达因 is a company operating in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and distribution of pharmaceutical and healthcare products.
